DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

2 API Suppliers
2 Listed Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 31637-97-5, Etofibrate [inn], 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate, Ethofibrate, 23tf67g79m, Etofibrate (inn)

Molecular Formula

C₁₈H₁₈ClNO₅

Molecular Weight

363.8 g/mol

InChI Key

XXRVYAFBUDSLJX-UHFFFAOYSA-N

FDA UNII

23TF67G79M

Etofibrate is an orally-available combination of clofibrate and niacin linked together by an ester bond. In the body clofibrate and niacin separate, acting as a controlled-release formulation.

1 2D Structure

Etofibrate

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl pyridine-3-carboxylate

2.1.2 InChI

InChI=1S/C18H18ClNO5/c1-18(2,25-15-7-5-14(19)6-8-15)17(22)24-11-10-23-16(21)13-4-3-9-20-12-13/h3-9,12H,10-11H2,1-2H3

2.1.3 InChI Key

XXRVYAFBUDSLJX-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CC(C)(C(=O)OCCOC(=O)C1=CN=CC=C1)OC2=CC=C(C=C2)Cl

2.2 Other Identifiers

2.2.1 UNII

23TF67G79M

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Etofibrate Hydrochloride

2. Lipo-merz

3. Tricerol

2.3.2 Depositor-Supplied Synonyms

1. 31637-97-5

2. Etofibrate [inn]

3. 2-[2-(4-chlorophenoxy)-2-methylpropanoyl]oxyethyl Pyridine-3-carboxylate

4. Ethofibrate

5. 23tf67g79m

6. Etofibrate (inn)

7. Lipo-merz

8. 2-hydroxyethyl Nicotinate 2-(p-chlorophenoxy)-2-methylpropionate (ester)

9. Etofibrato

10. Etofibratum

11. 2-(2-(4-chlorophenoxy)-2-methylpropanoyloxy)ethyl Nicotinate

12. Etofibratum [inn-latin]

13. Etofibrato [inn-spanish]

14. Einecs 250-743-1

15. Unii-23tf67g79m

16. Etofibrate [mi]

17. Etofibrate [mart.]

18. Schembl3122

19. 3-pyridinecarboxylic Acid, 2-[2-(4-chlorophenoxy)-2-methyl-1-oxopropoxy]ethyl Ester

20. Etofibrate [who-dd]

21. Mls006010106

22. Etofibrate, Analytical Standard

23. Chembl358150

24. Dtxsid80185521

25. Chebi:135535

26. Hms3652n04

27. 2-((2-(4-chlorophenoxy)-2-methylpropanoyl)oxy)ethyl Nicotinate

28. Bcp07572

29. Hy-a0127

30. Zinc2019929

31. Mfcd00865727

32. 2-(p-chlorophenoxy)-2-methylpropionic Acid 2-(nicotinoyloxy)ethyl Ester

33. Akos025311314

34. Ccg-268206

35. Db08983

36. 121ge005

37. Ac-23121

38. As-16847

39. Smr002529563

40. Cs-0017444

41. E1359

42. Ft-0660287

43. S4264

44. Sw219681-1

45. D07187

46. T72280

47. 637e975

48. Q-201101

49. Q4116990

2.4 Create Date

2005-08-08

3 Chemical and Physical Properties

Molecular Formula	C₁₈H₁₈ClNO₅
Molecular Weight	363.8 g/mol
XLogP3	3.5
Hydrogen Bond Donor Count	0
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	9
Exact Mass	363.0873504 g/mol
Monoisotopic Mass	363.0873504 g/mol
Topological Polar Surface Area	74.7 Å²
Heavy Atom Count	25
Formal Charge	0
Complexity	449
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Hypolipidemic Agents

Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)

Anticholesteremic Agents

Substances used to lower plasma cholesterol levels. (See all compounds classified as Anticholesteremic Agents.)

4.2 ATC Code

C - Cardiovascular system

C10 - Lipid modifying agents

C10A - Lipid modifying agents, plain

C10AB - Fibrates

C10AB09 - Etofibrate

API SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Find Etofibrate manufacturers, exporters & distributors on PharmaCompass

Etofibrate

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers

2 Listed Suppliers

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?